US Continuous Glucose Monitoring Market Share

Statistics for the 2023 & 2024 US Continuous Glucose Monitoring market share, created by Mordor Intelligence™ Industry Reports. US Continuous Glucose Monitoring share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of US Continuous Glucose Monitoring Industry

The United States Continuous Glucose Monitoring Market is consolidated, with few significant players. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, have sent Dexcom ahead on its way in the race to create an artificial pancreas system rather than merely offering a boost to the continuous glucose monitoring market. There have been constant innovations driven by manufacturers such as Abbott and Medtronic while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.

US Continuous Glucose Monitoring Market Leaders

  1. Abbott Diabetes Care

  2. Dexcom Inc.

  3. Ascensia Diabetes Care

  4. Medtronic

  5. GlySens

*Disclaimer: Major Players sorted in no particular order

US Continuous Glucose Monitoring Market Concentration

United States Continuous Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)